Hypoglycemic, hypocholesterolemic and ocular-protective effects of an aqueous extract of the rhizomes of sansevieria senegambica baker (Agavaceae) on alloxan-induced diabetic wistar rats

American Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 2, 2012, Pages 48-66

  Chigozie, Ikewuchi Jude ^a   Chidinma, Ikewuchi Catherine ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

Author keywords

Apigenin; Haematology; Hypoglycemia; Lipid profile; Ocular oxidative stress; Quercetin; Sansevieria senegambica baker

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; APIGENIN; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOCHANIN A; CATECHIN; CHLORIDE; CHOLESTEROL ESTER; EPICATECHIN; GLUCOSE; HEMOGLOBIN; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; METFORMIN; NARINGENIN; ORGANONITROGEN DERIVATIVE; PLANT EXTRACT; POTASSIUM; PROTEIN; QUERCETIN; SANSEVIERIA SENEGAMBICA EXTRACT; SODIUM; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; UREA NITROGEN; VERY LOW DENSITY LIPOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BICARBONATE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CELL VOLUME; CHEMICAL COMPOSITION; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ERYTHROCYTE; EYE PROTECTION; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HEMATOCRIT; HEMATOLOGY; HEMOGLOBIN BLOOD LEVEL; HYPOCHOLESTEROLEMIA; HYPOGLYCEMIA; IMMUNOMODULATION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LIVER PROTECTION; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; RHIZOME; SANSEVIERIA; SANSEVIERIA SENEGAMBICA; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

AGAVACEAE; RATTUS; RATTUS NORVEGICUS; SANSEVIERIA SENEGAMBICA;

EID: 84856072281     PISSN: 21504210     EISSN: 21504253     Source Type: Journal    
DOI: 10.3923/ajbmb.2012.48.66     Document Type: Article

References (94)

1. AOAC, 2006. Official Methods of Analysis of the AOAC. 18th Edn., Association of Official Analytical Chemists, Washington, DO, USA
2. Acuff, R.V., D.J. Cai, Z.B. Dong and D. Bell, 2007. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis., 6: 11-11
3. Ademuyiwa, O., R.N. Ugbaja, F. Idumebor and O. Adebawo, 2005. Blasma lipid profiles and risk of cardiovascular disease in occupational lead exposure in Abeokuta, Nigeria. Lipids Health Dis., 4: 19-19
4. American Diabetes Association, 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care, 27: S5-S10
5. Amoah, A.G., S.K. Owusu and S. Adjei, 2002. Diabetes in Ghana: A community based prevalence study in Greater Accra. Diabetes Res. Clin. Bract., 56: 197-205
6. Amos, A.F., D.J. McCarty and F. Zimmet, 1997. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet. Med., 14: S1-S85.
7. Assmann, G. and A.M. Jr. Gotto, 2004. HDL cholesterol and protective factors in atherosclerosis. Circulation, 109: III-8-III-14
8. Atalay, M. and D.E. Laaksonen, 2002. Oxidative stress and physical exercise. J. Sports Sei. Med, 1: 1-4
9. Baginski, E.S., S.S. Marie, W.L. Clark and B. Zak, 1973. Direct microdetermination of serum calcium. Clin. Chim. Acta, 46: 46-54
10. Bailey, C.J. and C. Day, 1989. Traditional plant medicines as treatments for diabetes. Diabetes Care, 12: 553-564
11. Basu, S.K., J.E. Thomas and S.N. Acharya, 2007. Prospects for growth in global utraceutical and functional food markets: A Canadian perspective. Aust. J. Basic Applied Sei., 1: 637-649
12. Beers, R.F. and I.W. Sizer, 1951. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Biol. Chem., 195: 130-140
13. Brehm, A., G. Pfeiler, G. Pacini, H. Vierhapper and M. Roden, 2004. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin. Chem., 50: 2316-2322
14. Brunzell, J.D, M. Davidson, CD. Furberg, R.D. Goldberg, B.V. Howard, J.H. Stem and J.L. Witztum, 2008. Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J. Am. Coll. Cardiol, 51: 1512-1524
15. Burcelin, R., M. Eddouks, J. Maury, J. Kande, R. Assan and J. Girard, 1995. Excessive glucose production, rather than Insulin resistance, account for hyperglycemia in recent onset streptozocin-diabetic rats. Diabetol., 385: 283-290
16. Centers for Disease Control and Prevention, 2005. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. U.S. Department of Health and Human Services, Atlanta, GA
17. Chakravarthy, B.K., S. Gupta and K.D. Gode, 1982. Functional B-cells regeneration in the islets of pancreas in alloxan induced diabetic rats by (-) epicatechin. Life Sei., 31: 2693-2697
18. Cheesbrough, M., 2004. District Laboratory Practice in Tropical Countries. Cambridge University Press, Cambridge, UK., pp: 62-70
19. Chu, K.O, C.C. Wang, C.Y. Chu, M.S. Rogers, K.W. Choy and C.P. Pang, 2004. Determination of catechin and catechin gallates in tissues by liquid chromatography with colorimetric array detection and selective solid phase extraction. J. Chromatog. B, 810: 187-195
20. De Sousa, E., L. Zanatta, I. Seifriz, T.B. Creczynski-Pasa, M.G. Pizzolatti, B. Szpoganicz and F.R.M.B. Silva, 2004. Hypoglycemic effect and antioxidant potential of kaempferol-3,7-0-(a)- dirhamnoside from Bauhinia forcata leaves. J. Nat. Prod., 67: 829-832
21. Dillard, C.J. and J.B. German, 2000. Phy to chemicals: Nutraceuticals and human health. J. Food Agric. Sei., 80: 1744-1756
22. Dobiaova, M., 2004. Atherogenic index of plasma [Log(Triglycerides/HDL-Cholesterol)] theoretical and practical implications. Clin. Chem., 50: 1113-1115
23. Evans, W.C., 2005. A Taxonomic Approach to the Study of Medicinal Plants and Animal-Derived Drugs. In: Evans Pharmacognosy, Evans, W.C. (Ed.). Elsevier, India, pp: 15-40
24. Franz, M.J., J.P. Bantle, C.A. Beebe, J.D. Brunzell and J.L. Chiasson. et al., 2002. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 25: 148-198
25. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem, 18: 499-502.
26. Gutteridge, J.M.C. and S. Wilkins, 1982. Copper-dependent hydroxyl radical damage to ascorbic acid: Formation of a thiobarbituric acid-reactive product. FEBS Lett., 137: 327-330
27. Hartnett, M.E., R.D. Stratton, R.W. Browne, B.A. Rosner, R.J. Lanham and D. Armstrong, 2000. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care, 23: 234-240
28. Hemalatha, R., 2008. Anti-hepatotoxic and anti-oxidant defense potential of Tridax procumbens. Int. J. Green Pharm., 2: 164-169
29. Howes, R.M., 2006. Diabetes and Oxygen Free Radical Sophistry. Free Radical Publishing Co, USA
30. Huang, R.Y, Y.L. Yu, W.C. Cheng, C.N. OuYang, E. Fu and C.L. Chu, 2010. Immunosuppressive effect of quercetin on dendritic cell activation andfunction. J. Immunol, 184: 6815-6821
31. Hunter, Jr. F.E, J.M. Gebicki, P.E. Hoffstein, J. Weinstein and A. Scott, 1963. Swelling and lysis of rat liver mitochondria induced by ferrous ions. J. Biol. Chem, 238: 828-835
32. Ikewuchi, J.C. and C.C. Ikewuchi, 2009a. Alteration of plasma lipid profile and atherogenic indices of cholesterol loaded rats by Tridax procumbens Linn.: Implications for the management of obesity and cardiovascular diseases. Biokemistri, 21: 95-99
33. Ikewuchi, J.C. and C.C. Ikewuchi, 2009b. Alteration of plasma lipid profiles and atherogenic indices by Stachytarphetajamaicensish. (Vahl). Biokemistri, 21: 71-77
34. Ikewuchi, C.C, 2010. Effect of aqueous extract of Sansevieria senegambica Baker on plasma chemistry, lipid profile and atherogenic indices of alloxan treated rats: Implications for the management of cardiovascular complications in diabetes mellitus. Pac. J. Sei. Technol, 11: 524-531
35. Ikewuchi, J.C. and C.C. Ikewuchi, 2010. Hypocholesterolaemic effect of aqueous extract of Acalypha wilkesiana Godseffiana Muell Arg on rats fed egg yolk supplemented diet: Implications for cardiovascular risk management. Res. J. Sei. Technol, 2: 78-81
36. Ikewuchi, J.C. and C.C. Ikewuchi, 2011. Iodometric determination of the ascorbic acid (vitamin C) content of some fruits consumed in a university community in Nigeria. Global J. Pure Applied Sei., 17: 47-49
37. Ikewuchi, C.C, J.C. Ikewuchi, E.O. Ayalogu and E.N. Onyeike, 2011a. Weight reducing and hypocholesterolaemic effect of aqueous leaf extract of Sansevieria senegambica baker on sub-chronic salt-loaded rats: Implication for the reduction of cardiovascular risk. Res. J. Pharm. Tech, 4: 725-729
38. Ikewuchi, J.C, E.N. Onyeike, A.A. Uwakwe and C.C. Ikewuchi, 2011b. Effect of aqueous extract of the leaves of Acalypha wilkesiana Godseffiana Muell Arg (Euphorbiaceae) on the haematology, plasma biochemistry and ocular indices of oxidative stress in alloxan induced diabetic rats. J. Ethnopharmacol, 137: 1415-1424
39. Imai, K, T. Aimoto, M. Sato and R. Kimura, 1991. Antioxidative effect of protoporphyrin on lipid peroxidation in tissue homogenates of intravenously administered rats. J. Pharmacobiodyn, 14: 20-24
40. Imoisili, O.E. and A.E. Sumner, 2009. Preventing diabetes and atherosclerosis in sub-Saharan Africa: Should the metabolic syndrome have a role? Curr. Cardiovasc. Risk Rep, 3: 161-167
41. Jarvis, D.I., L. Myer, H. Klemick, L. Guarino and M. Smale et al., 2000. A Training Guide for In situ Conservation On-farm. Bioversity International, Rome, Italy, ISBN-13: 9789290434528, Pages: 161.
42. Jung, U.J., M.K. Lee, K.S. Jeong and M.S. Choi, 2004. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr, 134: 2499-2503
43. Kaushansky, K., 2009. Determinants of platelet number and regulation of thrombopoiesis. Am. Soc. Hematol. Educ. Program Book, 2009: 147-152
44. Kengne, A.P., A.G. Amoah and J.C. Mbanya, 2005. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation, 112: 3592-3601
45. Kini, F., H. Millogo-Kone, I.P. Guissou, M. Lompo, O. Nacoulma and S. Asimi, 2009. Evaluation of flavonoids and total phenolic contents of stem bark and leaves of Parkia biglobosa (Jacq.) Benth. (Mimosaceae)-free radical scavenging and antimicrobial activities. Res. J. Med. Sei., 3: 70-74
46. Krauss, R.M., P.J. Blanche, R.S. Rawlmgs, H.S. Fernstrom and P.T. Williams, 2006. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am. J. Clin. Nutr, 83: 1025-1031
47. Kuo, Y.C, L.M. Yang and L.C. Lin, 2004. Isolation and immunomodulatory effect of flavonoids from Syzygium samarangense. Planta Med, 70: 1237-1239
48. Lau, T, 2008. A healthy way to live: The occurrence, bioactivity, biosynthesis and synthesis of kaempferol. Chemistry, 150: 1-3.
49. Lee, J.S, 2006. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats. Life Sei, 79: 1578-1584
50. Lee, S.H, Y.B. Park, K.H. Bae, S.H. Bok, Y.K. Kwon, E.S. Lee and M.S. Choi, 1999. Cholesterol-lowering activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase and acyl coenzyme A: Cholesterol acyltransferase in rats. Ann. Nutr. Metabol, 43: 173-180
51. Libby, P, 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation, 104: 365-372
52. Lichtenstein, A.H, L.J. Appel, M. Brands, M. Carnethon and S. Daniels et al., 2006. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation, 114: 82-96
53. Lin, M.K, Y.L. Yu, K.C. Chen, W.T. Chang and M.S. Lee et al, 2011. Kaempferol from Semen cuscutae attenuates the immune function of dendritic cells. Immunobiology, 216: 1103-1109
54. Liu, J, C. Sempos, R. Donahue, J. Dorn, M. Trevisan and S.M. Grundy, 2005. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care, 28: 1916-1921
55. Lopes, H.F, H.B. Silva, J.A. Soares, B. Filho and F.M. Consohm-Colombo et al, 1997. Lipid metabolism alterations in normotensive subjects with positive history of hypertension. Hypertension, 30: 629-631
56. Maritim, A.C., R.A. Sanders and J.B. Watkins, 2003. Diabetes, oxidative stress and antioxidants: A review. J. Biochem. Mol. Toxicol, 17: 24-38
57. Maroo, J, V.T. Vasu, R. Aalinkeel and S. Gupta, 2002. Glucose lowering effect of aqueous of Enicostemma littorale Blume in diabetes: A possible mechanism of action. J. Ethnopharmacol, 81:317-320
58. Martirosyan, D.M., L.A. Miroshnichenko, S.N. Kulakova, A.V. Pogojeva and V.l. Zoloedov, 2007. Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis, 6: 1-12.
59. McBride, P.E., 2007. Triglycerides and risk for coronary heart disease. JAMA., 298: 336-338
60. Middleton, Jr. E., C. andaswami and T.C. Theoharides, 2000. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev., 52:673-751
61. Misra, H.P. and J. Fridovich, 1972. The role of Superoxide dismutase anion in the antioxidation of epinephrine and a simple assay for Superoxide dismutase. J. Biol. Chem., 247: 3170-3175
62. Moreno, P.R., E. Falk, I.F. Palacios, J.B. Newell, V. Fuster and J.T. Fallon, 1994. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation, 90: 775-778
63. Omobuwajo, O.R., G.O. Alade and A. Sowemimo, 2008. Indigenous knowledge and practices of women herb sellers of Southwestern Nigeria. Indian J. Trad. Know., 7: 505-510
64. Ong, K.C. and H.E. Khoo, 1996. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem. Pharmacol., 51:423-429
65. Panda, S. and A. Kar, 2007. Apigenin (4',5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J. Pharm. Pharmacol., 59: 1543-1548
66. Radwan, M.A., 2001. Enhancement of absorption of insulin-loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats. DrugDev. Ind. Pharm., 27: 981-989
67. Rajdl, D., J. Racek, A. Steinerova, Z. Novotny, F. Stozicky, L. Trefil and K. Siala, 2005. Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol. Res., 54: 429-436
68. Rang, H.P., MM. Dale, JM. Ritter and P.K Moore, 2005. Pharmacology. 5th Edn., Elsevier, India
69. Rowe, J.W., J.D. obin, RM. Rosa and R. Andres, 1980. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism, 29: 498-502
70. Samuel, V.T., D.S.J. Murthy, K Dattatreya, P.S. Babu and S.S. Johncy, 2010. Impaired antioxidant defence mechanism in diabetic retinopathy. J. Clin. Diadnos. Res., 4: 3429-3436
71. Sen, G., S. Mandal, S.S. Roy, S. Mukhopadhyay and T. Biswas, 2005. Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis. Free Radic. Biol. Med, 38: 1257-1264
72. Shen, G.X., 2007. Lipid disorders in diabetes mellitus and current management. Curr. Pharmaceut. Anal, 3: 17-24
73. Shepherd, J, 1998. Identifying patients at risk for coronary heart disease: Treatment implications. Eur. Heart J, 19: 1776-1783
74. Sobngwi, E, F. Mauvais-jarvis, P. Vexiau, J.C. Mbanya and J.F. Gautier, 2001. Diabetes in Africans Part 1: Epidemiology and clinical specificities. Diabetes Metab, 27: 628-634
75. Soetan, K.O, 2008. Pharmacological and other beneficial effects of antinutritional factorsnin plants-Areview. Afr. J. Biotechnol, 7: 4713-4717
76. Stadelmann, C, 2007. Recent advances in the neuropathology of multiple sclerosis. Rev. Neurol, 163:657-661
77. Sternberg, Z, K. Chadha, A. Lieberman, A. Drake, D. Hojnacki, B. Weinstock-Guttman and F. Munschauer, 2009. Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: Additive effects of IFN-ß. J. NeuromfLamm, 6: 28-28.
78. Sternberg, Z, K. Chadha, A. Lieberman, D. Hojnacki and A. Drake et al., 2008. Quercetin and interferon-â modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. J. Neuroimmunol., 205: 142-147
79. Takeda, Y., S. Suzuki, T. Fukutomi, H. Kondo and M. Sugiura et al., 2003. Elevated white blood cell count as a risk factor of coronary artery disease: Inconsistency between forms of the disease. Japan Heart J., 44: 201-211
80. Taniguchi, A., M. Fukushima, Y. Seino, M. Sakai and S. Yoshii at al., 2003. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetes patients. Metabolism, 52: 1246-1249
81. Tapas, A.R., D.M. Sakarkar and R.B. Kakde, 2008. Flavonoids as nutraceuticals: A review. Trop. J. Pharm. Res, 7: 1089-1099
82. Taylor, A, 1993. Cataract: Relationships between nutrition and oxidation. J. Am. Coll. Nutr, 12: 138-146
83. USDA, 2008. Agricultural research service, germplasm resources information network (GRIN). GRIN taxonomy for plants. United States Department of Agriculture, USA
84. Usoro, C.A.O, C.C. Adikwuru, I.N. Usoro and A.C. Nsonwu, 2006. Lipid profile of postmenopausal women in calabar, Nigeria. Pak. J. Nutr, 5: 79-82
85. Van der Wal, A.C., A.E. Becker, CM. van der Loos and P.K. Das, 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation, 89: 36-44
86. Varma, S.D., 1991. Scientific basis of medical therapy of cataracts by antioxidants. Am. J. Clin. Nutr, 53: 335S-345S
87. Vessal, M, M. Hemmati and M. Vasei, 2003. Antidiabetic effects of quercetin in streptozocin induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol, 135C: 357-364
88. Vinardell, M.P. and M. Mitjans, 2008. Immunomodulatory effects of polyphenols. Electronic J. Environ. Agric. Food Chem, 7: 3356-3362
89. WHO, 2004. Diabetes Action Now: An Initiative of the World Health Organization and International Diabetes Federation. WHO Publication, Switzerland
90. Wardlaw, G.M, 1999. Perspectives in Nutrition. 4th Edn, McGraw-Hill, London
91. Wild, S, G. Roglic, A. Green, R. Sicree and H. King, 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27: 1047-1053
92. Wollf, S.P, 1993. Diabetes mellitus and free radicals: Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull, 49: 642-652
93. Yoon, M.S., J.S. Lee, B.M. Choi, Y.I. Jeong and CM. Lee et al., 2006. Apigenm inhibits immunostimulatory function of dendritic cells: Implication of immunotherapeutic adjuvant. Mol. Pharmacol, 70: 1033-1044
94. Zicha, J, J. Kunes and M.A. Devynck, 1999. Abnormalities of membrane function and lipid metabolism in hypertension: A review. Am. J. Hypertens, 12: 315-331.